Roche, AbbVie leukemia drug superior to older medicine in study

(Reuters) – Patients with a type of leukemia that had relapsed who received the new drug Venclexta in combination with Rituxan went significantly longer without the disease worsening than those treated with Rituxan and Treanda, according to interim results from a pivotal late stage study released on Tuesday.


Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *